{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T05:46:43Z","timestamp":1763358403437},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.lpm.2010.05.020","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T10:29:37Z","timestamp":1284719377000},"page":"1164-1171","source":"Crossref","is-referenced-by-count":2,"title":["\u00c9volution de la prise en charge pharmacologique de l\u2019arthrose\u00a0: les bioth\u00e9rapies"],"prefix":"10.1016","volume":"39","author":[{"given":"Xavier","family":"Chevalier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2010.05.020_bib0005","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S1297-319X(03)00129-5","article-title":"Structure-modifying agents for osteoarthritis: an update","volume":"71","author":"Richette","year":"2004","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.lpm.2010.05.020_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis. Part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartil"},{"key":"10.1016\/j.lpm.2010.05.020_bib0015","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F","article-title":"Review: osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets","volume":"44","author":"Pelletier","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0020","article-title":"Synovial tissue from patients with early osteoarthritis exhibits prominent features of inflammation","volume":"46","author":"Benito","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0025","first-page":"952","article-title":"Synovitis predicts the arthroscopic progression of medial tibiofemoral knee osteoarthritis","volume":"44","author":"Ayral","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0030","doi-asserted-by":"crossref","DOI":"10.1097\/01.blo.0000144854.66565.8f","article-title":"The role of cytokines in cartilage matrix degeneration in osteoarthritis","volume":"427","author":"Goldring","year":"2004","journal-title":"Clin Orthop Rel Res"},{"key":"10.1016\/j.lpm.2010.05.020_bib0035","first-page":"1411","article-title":"Targeted anti-cytokine therapies for osteoarthritis","volume":"190","author":"Chevalier","year":"2006","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.lpm.2010.05.020_bib0040","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0753-3322(97)87727-X","article-title":"Up-regulation of enzymatic activity by interleukin-1\u00a0in osteoarthritis","volume":"51","author":"Chevalier","year":"1997","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.lpm.2010.05.020_bib0045","article-title":"Anticytokine treatment of established type II collagen-induced arthritis in DBA\/1\u00a0mice: a comparative study using anti-TNFalpha, anti-IL-1alpha\/beta and IL-1Ra","volume":"58","author":"Joosten","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0050","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/art.11355","article-title":"IL-1b converting enzyme, inducible nitric oxide synthase, or stromelysin 1\u00a0accelerates the development of knee osteoarthritis in mice after surgical trans section of the medial collateral ligament and partial medial menisectomy","volume":"48","author":"Clements","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0304-3959(01)00433-X","article-title":"Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8\u00a0induce persistent mechanical nociceptor hypersensitivity","volume":"96","author":"Sachs","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.lpm.2010.05.020_bib0060","first-page":"22","article-title":"Clinical and radiological effects of anakinra in patients with rheumatoid arthritis","volume":"42","author":"Breshinan","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.lpm.2010.05.020_bib0065","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780390914","article-title":"Chondroprotective effect of intra-articular injections of interleukin-1\u00a0receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1\u00a0expression","volume":"39","author":"Caron","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0070","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/art.1780400604","article-title":"In vivo suppression of early experimental osteoarthritis by interleukin-1\u00a0receptor antagonist using gene therapy","volume":"40","author":"Pelletier","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0075","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0002-9440(10)65368-0","article-title":"In vivo transfer of interleukin-1\u00a0receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthrosis progression","volume":"154","author":"Fernandes","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.lpm.2010.05.020_bib0080","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.orthres.2003.12.007","article-title":"Suppression of early experimental osteoarthritis by gene transfer of interleukin-1\u00a0antagonist and interleukin-10","volume":"22","author":"Zhang","year":"2004","journal-title":"J Orthop Res"},{"key":"10.1016\/j.lpm.2010.05.020_bib0085","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1097\/00029330-200608020-00009","article-title":"Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer","volume":"119","author":"Wang","year":"2006","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.lpm.2010.05.020_bib0090","first-page":"1317","article-title":"Safety study of intraarticular injection of interleukin 1\u00a0receptor antagonist in patients with painful knee osteoarthritis: a multicenter study","volume":"32","author":"Chevalier","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.05.020_bib0095","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/art.24096","article-title":"Intra-articular injection of Anakinra (r-met-huIL-1ra) in osteoarthritis of the knee: a multicenter, randomized, double-blind placebo-controlled study","volume":"61","author":"Chevalier","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0100","first-page":"S70","article-title":"MRI evaluation of the synovial membrane after single intra-articular injection of Anakinra in 7\u00a0patients with osteoarthritis of the knee suggests anti-inflammatory effect","volume":"52(Suppl 9)","author":"Loeuille","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0105","first-page":"1650","article-title":"A high interleukin 1\u00a0receptor antagonist\/IL-1beta ratio occurs naturally in knee osteoarthritis","volume":"35","author":"Richette","year":"2008","journal-title":"Rheumatol"},{"issue":"Suppl 9","key":"10.1016\/j.lpm.2010.05.020_bib0110","first-page":"1684","article-title":"Results of a randomised controlled trial of AMG 108 (a fully monoclonal human antibody to IL1R type 1) in patients with osteoarthritis of the knee","volume":"56","author":"Cohen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0115","article-title":"The role of activated synovial macrophages in osteoarthritis","volume":"16(Suppl 4)","author":"Bondenson","year":"2008","journal-title":"Osteoarthritis Cartil"},{"key":"10.1016\/j.lpm.2010.05.020_bib0120","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/ard.2006.053272","article-title":"Successful treatment of inflammatory knee osteoarthritis with tumour necrosis factor blockade","volume":"65","author":"Grunke","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.05.020_bib0125","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.berh.2004.05.010","article-title":"Erosive osteoarthritis","volume":"18","author":"Punzi","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.lpm.2010.05.020_bib0130","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/BOR.0b013e32802106a8","article-title":"Hand osteoarthritis: an increasing need for treatment and rehabilitation","volume":"19","author":"Kloppenburg","year":"2007","journal-title":"Curr Opinion Rheumatol"},{"key":"10.1016\/j.lpm.2010.05.020_bib0135","article-title":"\u00c0 propos d\u2019un cas d\u2019arthrose digitale \u00e9rosive\u00a0: r\u00e9ponse spectaculaire aux anti-TNF alpha","volume":"71","author":"Avouac","year":"2004","journal-title":"Rev Rhum"},{"key":"10.1016\/j.lpm.2010.05.020_bib0140","first-page":"1323","article-title":"A pilot study of tumor necrosis factor inhibition in erosive\/inflammatory osteoarthritis of the hands","volume":"34","author":"Magnano","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.lpm.2010.05.020_bib0145","article-title":"Infliximab might be protective against progressive interphalangeal osteoarthritis","volume":"67(Suppl. II)","author":"G\u00fcler-Y\u00fcksel","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lpm.2010.05.020_bib0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/ar2563","article-title":"Gene therapy for rheumatic diseases: 1998\u20132008","volume":"11","author":"Evans","year":"2009","journal-title":"Arthritis Res Ther"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210004343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210004343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T21:28:05Z","timestamp":1559683685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498210004343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S0755498210004343"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2010.05.020","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}